Skip to main content
. 2022 May 14;12:8008. doi: 10.1038/s41598-022-11760-1

Figure 11.

Figure 11

Immunohistochemical staining of UBE2C in the tissues and cell lines of the EC. (A) Expression of UBE2C in the EC. (B) Expression of UBE2C in normal esophageal tissues. (C) Expression of UBE2C in esophageal cancer cell line kyse150. (D) Expression of UBE2C in esophageal cancer cell line Eca109. (E) Expression of UBE2C in esophageal cancer cell line TE-1. (F) Expression of UBE2C in HEEC (normal esophageal cell line) . (G) Expression of UBE2C in the tissue microarray assay of 150 patients with esophageal cancer. (H) Differential expression analysis of UBE2C in cancer and adjacent tissues in the tissue microarray assay. Paired sample t-test was used to compare cancer and adjacent samples. ***P < 0.001. (I) Subject operating characteristic (ROC) curve analysis and area under curve (AUC) statistics were used to evaluate the ability of UBE2C to distinguish esophageal cancer from adjacent normal tissues.(AUC:0.879).